Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Related Citations for PubMed (Select 20044046)

1.

Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1.

Huang S, Kaw M, Harris MT, Ebraheim N, McInerney MF, Najjar SM, Lecka-Czernik B.

Bone. 2010 Apr;46(4):1138-45. doi: 10.1016/j.bone.2009.12.020. Epub 2010 Jan 4.

2.

Carcinoembryonic antigen-related cell adhesion molecule 1: a link between insulin and lipid metabolism.

DeAngelis AM, Heinrich G, Dai T, Bowman TA, Patel PR, Lee SJ, Hong EG, Jung DY, Assmann A, Kulkarni RN, Kim JK, Najjar SM.

Diabetes. 2008 Sep;57(9):2296-303. doi: 10.2337/db08-0379. Epub 2008 Jun 10.

3.

Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice.

Lee SJ, Heinrich G, Fedorova L, Al-Share QY, Ledford KJ, Fernstrom MA, McInerney MF, Erickson SK, Gatto-Weis C, Najjar SM.

Gastroenterology. 2008 Dec;135(6):2084-95. doi: 10.1053/j.gastro.2008.08.007. Epub 2008 Aug 20.

4.

Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1.

Park SY, Cho YR, Kim HJ, Hong EG, Higashimori T, Lee SJ, Goldberg IJ, Shulman GI, Najjar SM, Kim JK.

Am J Physiol Endocrinol Metab. 2006 Sep;291(3):E517-24. Epub 2006 Apr 25.

5.

Energy-restricted diet benefits body composition but degrades bone integrity in middle-aged obese female rats.

Shen CL, Zhu W, Gao W, Wang S, Chen L, Chyu MC.

Nutr Res. 2013 Aug;33(8):668-76. doi: 10.1016/j.nutres.2013.05.008. Epub 2013 Jun 24.

PMID:
23890357
6.

Inhibitory effects of high glucose/insulin environment on osteoclast formation and resorption in vitro.

Xu F, Ye YP, Dong YH, Guo FJ, Chen AM, Huang SL.

J Huazhong Univ Sci Technolog Med Sci. 2013 Apr;33(2):244-9. doi: 10.1007/s11596-013-1105-z. Epub 2013 Apr 17.

PMID:
23592138
7.

Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program.

Rosen CJ, Ackert-Bicknell CL, Adamo ML, Shultz KL, Rubin J, Donahue LR, Horton LG, Delahunty KM, Beamer WG, Sipos J, Clemmons D, Nelson T, Bouxsein ML, Horowitz M.

Bone. 2004 Nov;35(5):1046-58.

PMID:
15542029
8.

TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.

Kanazawa K, Kudo A.

J Bone Miner Res. 2005 May;20(5):840-7. Epub 2004 Dec 20.

PMID:
15824857
9.

Role of IGF-I signaling in regulating osteoclastogenesis.

Wang Y, Nishida S, Elalieh HZ, Long RK, Halloran BP, Bikle DD.

J Bone Miner Res. 2006 Sep;21(9):1350-8.

PMID:
16939393
10.

Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.

Gradin P, Hollberg K, Cassady AI, Lång P, Andersson G.

Cells Tissues Organs. 2012;196(1):68-81. doi: 10.1159/000330806. Epub 2012 Jan 12.

PMID:
22248481
11.

CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation.

Abou-Rjaily GA, Lee SJ, May D, Al-Share QY, Deangelis AM, Ruch RJ, Neumaier M, Kalthoff H, Lin SH, Najjar SM.

J Clin Invest. 2004 Oct;114(7):944-52.

12.

Type 2 diabetic mice demonstrate slender long bones with increased fragility secondary to increased osteoclastogenesis.

Kawashima Y, Fritton JC, Yakar S, Epstein S, Schaffler MB, Jepsen KJ, LeRoith D.

Bone. 2009 Apr;44(4):648-55. doi: 10.1016/j.bone.2008.12.012. Epub 2008 Dec 24.

13.

Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties.

Wang CJ, Chen IP, Koczon-Jaremko B, Boskey AL, Ueki Y, Kuhn L, Reichenberger EJ.

Bone. 2010 May;46(5):1306-15. doi: 10.1016/j.bone.2010.01.380. Epub 2010 Feb 1.

14.

Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.

Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.

J Bone Miner Res. 2005 Sep;20(9):1659-68. Epub 2005 May 2.

PMID:
16059637
15.

Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling.

Samee N, Geoffroy V, Marty C, Schiltz C, Vieux-Rochas M, Levi G, de Vernejoul MC.

Am J Pathol. 2008 Sep;173(3):773-80. doi: 10.2353/ajpath.2008.080243. Epub 2008 Jul 31.

16.

Cholesterol-sensing receptors, liver X receptor alpha and beta, have novel and distinct roles in osteoclast differentiation and activation.

Robertson KM, Norgård M, Windahl SH, Hultenby K, Ohlsson C, Andersson G, Gustafsson JA.

J Bone Miner Res. 2006 Aug;21(8):1276-87.

PMID:
16869726
18.

High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage.

Geoffroy V, Kneissel M, Fournier B, Boyde A, Matthias P.

Mol Cell Biol. 2002 Sep;22(17):6222-33.

19.

Targeted disruption of ephrin B1 in cells of myeloid lineage increases osteoclast differentiation and bone resorption in mice.

Cheng S, Zhao SL, Nelson B, Kesavan C, Qin X, Wergedal J, Mohan S, Xing W.

PLoS One. 2012;7(3):e32887. doi: 10.1371/journal.pone.0032887. Epub 2012 Mar 5.

20.

Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.

Okayasu M, Nakayachi M, Hayashida C, Ito J, Kaneda T, Masuhara M, Suda N, Sato T, Hakeda Y.

J Biol Chem. 2012 Jun 1;287(23):19229-41. doi: 10.1074/jbc.M111.323600. Epub 2012 Apr 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk